STC
LAB icon

SEI Trust Company’s Standard BioTools LAB Stock Holding History

SEI Trust Company’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-29,100
Closed -$638K – 1649
2013
Q3 		$638K Sell
29,100
-11,808
-29% -$232K 0.01% 1019
2013
Q2 		$714K Buy
+40,908
New +$718K 0.01% 828

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SEI Trust Company's LAB Position: Q4 2013 in Review

SEI Trust Company sold out of Standard BioTools (LAB) in Q4 2013, closing a stake of 29,100 shares — an estimated $638K sold.

SEI Trust Company first reported a position in LAB in Q2 2013 and held it in 2 quarters. The position peaked at $714K in Q2 2013. 100 funds tracked by Wall St. Rank hold LAB as of Q4 2013.

  • SEI Trust Company reported no remaining Standard BioTools position as of Q4 2013 after selling out during the quarter.
  • SEI Trust Company sold 29,100 Standard BioTools shares in Q4 2013, an estimated $638K.
  • SEI Trust Company first reported a position in Standard BioTools in Q2 2013 and held it in 2 quarters.
  • SEI Trust Company's Standard BioTools position peaked at $714K in Q2 2013.
  • 100 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2013.

Based on SEI Trust Company's 13F filing for Q4 2013, filed 21 Jan 2014.